{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:35:04Z","timestamp":1790361304457,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bj.2024.100698","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T12:31:45Z","timestamp":1706185905000},"page":"100698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer"],"prefix":"10.1016","volume":"47","author":[{"given":"John Wen-Cheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Juan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Yih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-En","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Mo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Tang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ming","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4324-7743","authenticated-orcid":false,"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2024.100698_bib1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3389\/fmicb.2018.01835","article-title":"The human gut microbiome - a potential controller of wellness and disease","volume":"9","author":"Kho","year":"2018","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.bj.2024.100698_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s43440-022-00401-z","article-title":"Repetitive transcranial direct current stimulation modulates the brain-gut-microbiome axis in obese rodents","volume":"74","author":"Ziomber-Lisiak","year":"2022","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bj.2024.100698_bib3","article-title":"Roles of microbiota in cancer: from tumor development to treatment","volume":"2022","author":"Bagheri","year":"2022","journal-title":"JAMA Oncol"},{"issue":"6 suppl","key":"10.1016\/j.bj.2024.100698_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1200\/JCO.2017.35.6_suppl.462","article-title":"Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors","volume":"35","author":"Derosa","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.smim.2011.11.008","article-title":"Intestinal microbiota: shaping local and systemic immune responses","volume":"24","author":"Molloy","year":"2012","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.bj.2024.100698_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6161","key":"10.1016\/j.bj.2024.100698_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"issue":"6264","key":"10.1016\/j.bj.2024.100698_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bj.2024.100698_bib10","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.cell.2021.09.024","article-title":"Microbiota regulates intratumoral monocytes to promote anti-tumor immune responses","volume":"184","author":"McCoy","year":"2021","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.bj.2024.100698_bib11","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","article-title":"Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment","volume":"184","author":"Lam","year":"2021","journal-title":"Cell"},{"issue":"6371","key":"10.1016\/j.bj.2024.100698_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.bj.2024.100698_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.bj.2024.100698_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bj.2024.100698_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/dnares\/dsw002","article-title":"The gut microbiome of healthy Japanese and its microbial and functional uniqueness","volume":"23","author":"Nishijima","year":"2016","journal-title":"DNA Res"},{"issue":"7","key":"10.1016\/j.bj.2024.100698_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022109","article-title":"Comparative analysis of Korean human gut microbiota by barcoded pyrosequencing","volume":"6","author":"Nam","year":"2011","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bj.2024.100698_bib17","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/jcm11185479","article-title":"Composition of the gut microbiota associated with the response to immunotherapy in advanced cancer patients: a Chinese real-world pilot study","volume":"11","author":"Cheng","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s42003-021-01741-x","article-title":"Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation","volume":"4","author":"Sims","year":"2021","journal-title":"Commun Biol"},{"issue":"21","key":"10.1016\/j.bj.2024.100698_bib19","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1093\/bioinformatics\/btv401","article-title":"Error filtering, pair assembly and error correction for next-generation sequencing reads","volume":"31","author":"Edgar","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bj.2024.100698_bib20","doi-asserted-by":"crossref","first-page":"D633","DOI":"10.1093\/nar\/gkt1244","article-title":"Ribosomal Database Project: data and tools for high throughput rRNA analysis","volume":"42","author":"Cole","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bj.2024.100698_bib21","article-title":"SINTAX: a simple non-Bayesian taxonomy classifier for 16S and ITS sequences","author":"Edgar","year":"2016","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.bj.2024.100698_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/j.bj.2024.100698_bib23","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1869504","article-title":"Gut microbiota: impacts on gastrointestinal cancer immunotherapy","volume":"13","author":"Lau","year":"2021","journal-title":"Gut Microb"},{"issue":"10","key":"10.1016\/j.bj.2024.100698_bib25","first-page":"3171","article-title":"Alterations of fecal bacterial communities in patients with lung cancer","volume":"10","author":"Zhang","year":"2018","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13568-019-0763-z","article-title":"Altered diversity and composition of the gut microbiome in patients with cervical cancer","volume":"9","author":"Wang","year":"2019","journal-title":"Amb Express"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib27","doi-asserted-by":"crossref","first-page":"2096535","DOI":"10.1080\/2162402X.2022.2096535","article-title":"Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors","volume":"11","author":"Tonneau","year":"2022","journal-title":"OncoImmunology"},{"issue":"8","key":"10.1016\/j.bj.2024.100698_bib28","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","article-title":"The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC","volume":"14","author":"Jin","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.bj.2024.100698_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768957","article-title":"Mechanisms of immune checkpoint inhibitor-mediated colitis","volume":"12","author":"Westdorp","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/mdy507","article-title":"Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma","volume":"30","author":"Oliva","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.bj.2024.100698_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.bj.2024.100698_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2147\/JHC.S315696","article-title":"An exploratory study for the association of gut microbiome with efficacy of immune checkpoint inhibitor in patients with hepatocellular carcinoma","volume":"8","author":"Shen","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1757-4749-2-8","article-title":"Enteropathogenic Escherichia coli, Samonella, Shigella and Yersinia: cellular aspects of host-bacteria interactions in enteric diseases","volume":"2","author":"Reis","year":"2010","journal-title":"Gut Pathog"},{"issue":"3","key":"10.1016\/j.bj.2024.100698_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12799","article-title":"The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients","volume":"90","author":"Huang","year":"2019","journal-title":"Scand J Immunol"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.bj.2024.100698_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7150\/ijbs.22809","article-title":"Effect of IL-18 on the expansion and phenotype of human natural killer cells: application to cancer immunotherapy","volume":"14","author":"Senju","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"20","key":"10.1016\/j.bj.2024.100698_bib37","doi-asserted-by":"crossref","first-page":"32722","DOI":"10.18632\/oncotarget.16281","article-title":"Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bj.2024.100698_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.570484","article-title":"Fine particulate matter exposure alters pulmonary microbiota composition and aggravates pneumococcus-induced lung pathogenesis","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.bj.2024.100698_bib39","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1080\/21655979.2021.1972077","article-title":"The gut microbial diversity of colon cancer patients and the clinical significance","volume":"12","author":"He","year":"2021","journal-title":"Bioengineered"},{"issue":"6529","key":"10.1016\/j.bj.2024.100698_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.bj.2024.100698_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417024000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:44:53Z","timestamp":1733431493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417024000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2319417024000015"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2024.100698","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2024.100698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100698"}}